Loading…
B-cell activating factor (BAFF) promotes CpG ODN-induced B cell activation and proliferation
► B cells activation by CpG ODN is controversial. ► Purified bovine B cells express TLR9 in the absence of B cell receptor engagement. ► CpG ODNs do not promote significant proliferation of highly purified bovine B cells. ► Myeloid cells and/or BAFF significantly increase CpG-specific B cell activat...
Saved in:
Published in: | Cellular immunology 2011, Vol.271 (1), p.16-28 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | ► B cells activation by CpG ODN is controversial. ► Purified bovine B cells express TLR9 in the absence of B cell receptor engagement. ► CpG ODNs do not promote significant proliferation of highly purified bovine B cells. ► Myeloid cells and/or BAFF significantly increase CpG-specific B cell activation. ► BCR engagement does not augment CpG-specific B cell activation.
It is controversial whether naïve B cells are directly activated in response to TLR9 ligand, CpG ODN. Although bovine blood-derived CD21+ B cells express TLR9 and proliferate in response to CpG in mixed-cell populations, purified bovine B cells do not proliferate significantly in response to CpG ODN, even when the B cell receptor is engaged. When co-cultured with CD14+ myeloid cells and/or B-cell activating factor (BAFF), a cytokine produced by activated myeloid cells, there was a significant increase in CpG-specific B cell proliferation, and the number of large B cells in general or positive for CD25, all of which are markers for B cell activation. These data suggest that activated myeloid cells and BAFF prime B cells for significant CpG-specific activation. Understanding the signals required to mediate efficient CpG-induced, antigen-independent and T-cell independent activation of B cells has implications for polyclonal B cell activation and the development of autoimmune diseases. |
---|---|
ISSN: | 0008-8749 1090-2163 |
DOI: | 10.1016/j.cellimm.2011.05.016 |